Description
TRZ-GLP2 is a synthetic peptide designed as a powerful dual-receptor agonist. This innovative single-molecule polypeptide is engineered for exceptional stability and efficacy, targeting the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors. By activating these two key receptors involved in metabolic regulation, GLP2 represents a new frontier in peptide-based therapeutic development.
Reviews
There are no reviews yet.